Search
Thursday 30 July 2015
  • :
  • :

Afternoon Trade Stocks Highlights: Teradyne, (NYSE:TER), Firstmerit (NASDAQ:FMER), AstraZeneca (NYSE:AZN), Meritor (NYSE:MTOR)

During Wednesday’s Afternoon trade, Shares of Teradyne, Inc. (NYSE:TER), lost -0.05% to $18.55.

Teradyne, Inc. (TER) declared that it has accomplished the acquisition of Universal Robots, the leading supplier of collaborative robots; low-cost, easy-to-deploy and simple-to -program robots that work side by side with production workers to improve quality and enhance manufacturing efficiency. Collaborative robotics is a $100 million segment of the industrial robotics market growing at more than 50% per year.

Teradyne, Inc. provides automatic test equipment worldwide. The company’s Semiconductor Test segment designs, manufactures, sells, and supports semiconductor test products and services for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game applications, and others.

Shares of Firstmerit Corp (NASDAQ:FMER), declined -1.77% to $18.62, during its Afternoon trading session.

FirstMerit Corporation ( FMER ) stated second quarter 2015 net income of $56.6 million, or $0.33 per diluted share. This compares with $57.1 million, or $0.33 per diluted share, for the first quarter 2015 and $59.5 million, or $0.35 per diluted share, for the second quarter 2014.

Returns on average common equity (“ROE”) and average assets (“ROA”) for the second quarter 2015 were 7.85% and 0.90%, respectively, contrast with 8.08% and 0.93%, respectively, for the first quarter 2015 and 8.62% and 0.98%, respectively, for the second quarter 2014.

FirstMerit Corporation operates as the bank holding company for FirstMerit Bank N.A. that provides various banking, fiduciary, financial, insurance, and investment services to corporate, institutional, and individual customers. The company’s Commercial segment offers commercial term loans, revolving credit arrangements, asset-based lending, leasing, commercial mortgages, real estate construction lending, and letters of credit, in addition to treasury administration, government banking, international banking, merchant card, and other depository products and services.

AstraZeneca plc (ADR) (NYSE:AZN), during its Wednesday’s Afternoon trading session gained 0.06% to $32.83.

AstraZeneca plc (ADR) (AZN) declared that the U.S. Food and Drug Administration (FDA) has approved IRESSA® (gefitinib) as a first-line treatment in patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

IRESSA is a once daily oral EGFR-tyrosine kinase inhibitor (TKI), which inhibits the activity that contributes to intracellular signaling pathways implicated in the growth and survival of cancer cells. IRESSA was granted Orphan Drug Designation by the FDA in August 2014 for the treatment of EGFR mutation-positive advanced NSCLC.

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. Its principal products comprise Crestor for the treatment of dyslipidaemia and hypercholesterolemia; Seloken/Toprol-XL to control hypertension, and heart failure and angina; Onglyza for diabetes mellitus; Iressa for non-small cell lung cancer; Faslodex for breast cancer in post-menopausal women; and Zoladex for prostate cancer, breast cancer, and certain benign gynaecological disorders.

Finally, Meritor Inc (NYSE:MTOR), gained 8.88%, to $13.86.

Meritor, Inc. (MTOR) declared that it has purchased the majority of the assets at the Sypris Solutions, Inc. manufacturing facility in Morganton, North Carolina.

Brett Penzkofer, vice president and general manager of Meritor’s trailer business stated that Bringing the Morganton facility under the Meritor umbrella allows them to expand operations while demonstrating their continued commitment to supplying axle and suspension components to our customers

The facility currently manufactures trailer axle beams, and machines carriers and differentials for Meritor, in addition to producing light vehicle components for other customers.

Meritor, Inc. designs, develops, manufactures, sells, markets, distributes, services, and supports integrated systems, modules, and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors. It operates through two segments, Commercial Truck & Industrial, and Aftermarket & Trailer. The Commercial Truck & Industrial segment supplies drive train systems and components, counting axles, drivelines, and braking and suspension systems primarily for medium and heavy-duty trucks, off-highway, military, construction, bus and coach, fire and emergency, and other applications.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *